Australia's largest stock trading and investment forum Australia's #1 stock forum

RAC

Click for more information

1.18%

$1.67 race oncology ltd

RAC - Charts & Price Action, page-18213

First 18213 Last

Share
Profile

Follow
good1234

2,648 Posts.

427

03/12/23

09:20

Post #: 71240316
Share

Originally posted by Davisite: ↑

Assuming Race is at the same stage as IMU is where many investors go wrong. Race has two drugs, RC110 & RC220. RC110 is a Phase 3/4 asset that has made it all the way through to approval. RC220 is a reformulated version of RC110 designed for a much larger market. RC110 has completed more than 50 clinical trials including two modern AML trials where it performed very well in very difficult to treat patients.

The opportunity for RC220 is considerable (cardioprotection & m6A RNA) - it is an asset with multi-billion dollar market across dozens of cancers types. While RC220 is considered a pre-clinical asset from a purely regulatory perspective, it really isn’t from a risk perspective since it is designed to be identical in the patient as RC110 (it is certainly identical in all the animal studies). With RC220 you get all the benefits of a new drug and all the risk avoidance that comes with an old drug.

I am hopeful as more people understand what Race has that the SP will start to reflect the underlying value of the assets.

Expand

I do understand the confusion some shareholders have with your comments.

Yes we have 2 drugs, but will only advance one.

RC110 will not be commercialized, so to say we have 2 drugs is not correct.

RAC Price at posting: 85.0¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

There are more pages in this discussion • 4,392 more messages in this thread...

First 18213 Last

Add RAC (ASX) to my watchlist

(20min delay)
Last $1.67		Change -0.020(1.18%)		Mkt cap ! $282.9M

Open	High	Low	Value	Volume
$1.69	$1.69	$1.64	$48.19K	28.95K

Buyers (Bids)

No.	Vol.	Price($)
5	8279	$1.67

Sellers (Offers)

Price($)	Vol.	No.
$1.69	731	1

View Market Depth

No.	Vol.	Price($)
1	1	1.665
1	850	1.660
1	6132	1.655
1	6983	1.650
1	7485	1.645

Price($)	Vol.	No.
1.675	1199	1
1.685	734	2
1.690	2316	1
1.700	2	1
1.730	519	1

Last trade - 14.58pm 07/10/2024 (20 minute delay)

RAC (ASX) Chart